Mortality among U.S. adults with coexisting type 2 diabetes mellitus and malignant neoplasms: A nationwide observational study (1999–2024)
Authors:
Open Access
- 31 July 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (31) , e49969
Abstract
Type 2 diabetes mellitus (T2DM) and malignant neoplasms are among the most prevalent chronic diseases worldwide. When coexisting, they substantially increase morbidity and mortality. However, national trends in mortality among patients with coexisting T2DM and malignant neoplasms in the United States remain underexplored. We analyzed U.S. death certificates from the CDC WONDER database for individuals aged ≥ 25 years who died between 1999 and 2024 with both T2DM and malignant neoplasms listed anywhere on the death certificate (underlying or contributing causes). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age group, race/ethnicity, geographic region, and urbanization status. From 1999 to 2024, 357,910 U.S. deaths occurred among individuals in whom both Type 2 Diabetes Mellitus and Malignant Neoplasms were listed on the death certificate. The AAMR rose from 6.37 to 17.2 per 100,000, with an overall APC of + 3.84%. Men exhibited higher mortality than women. Older adults bore the greatest burden, though middle-aged adults also showed a sharp proportional rise. Hispanic and Asian populations experienced the steepest increases. The West region showed the most pronounced growth. State-level variation exceeded fivefold, with Nebraska reporting the highest AAMR and Nevada the lowest. nonmetropolitan areas maintained higher mortality throughout, but metropolitan areas demonstrated a steeper rise, narrowing the rural–urban gap. Mortality among individuals with coexisting T2DM and malignant neoplasms has risen substantially in the U.S., with disproportionate increases among men, minority populations, and urban residents. These findings highlight the urgent need for integrated strategies addressing diabetes control, cancer prevention, and health equity across demographic and geographic subgroups.Keywords
This publication has 13 references indexed in Scilit:
- Emerging trends and disparities in mortality due to coexisting atrial fibrillation and sepsis: A US nationwide observational study (1999–2023)Medicine, 2026
- Trends and Disparities in Cancer‐Related Mortality Among Adults With Diabetes in the United States: 1999–2019Endocrinology, Diabetes & Metabolism, 2025
- Diabetes and further risk of cancer: a nationwide population-based studyBMC Medicine, 2024
- Demographic and Regional Trends of Heart Failure–Related Mortality in Young Adults in the US, 1999-2019JAMA Cardiology, 2022
- Demographic and Regional Trends of Mortality in Patients With Aortic Dissection in the United States, 1999 to 2019Journal of the American Heart Association, 2022
- A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over timeScientific Reports, 2020
- Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in ChinaBMC Public Health, 2012
- Diabetes Mellitus Increased Mortality Rates More in Gender-Specific than in Nongender-Specific Cancer Patients: A Retrospective Study of 149,491 PatientsExperimental Diabetes Research, 2012
- Heterogeneity of Diabetes Outcomes Among Asians and Pacific Islanders in the U.S.Diabetes Care, 2011
- Diabetes and CancerDiabetes Care, 2010